Sanofi Signs Pact With Medco To Improve Patient Care
22 June 2011 - 3:40PM
Dow Jones News
French pharmaceutical group Sanofi SA (SAN.FR) said Wednesday it
signed an agreement with Medco Health Solutions Inc (MHS) and its
unit United BioSource Corp., or UBC, to better leverage the
real-world evidence generated during product development and
throughout the product lifecycle in order to improve the overall
quality of patient care.
MAIN FACTS:
- Under the terms of this multi-year agreement, Medco and UBC
will provide real-world input and comparative data into product
development strategy.
- This agreement will allow Sanofi to define the relative value
for products early in development, by more precisely identifying
patient populations in which drugs are most effective.
- It will also enable Sanofi to maximize the full value
potential of R&D innovation through early alignment of patient
population assessments, payer and medical needs. The objective is
to develop integrated solutions for patients by implementing novel
care models and to improve adherence and patient outcomes.
- Sanofi didn't release any financial details on the agreement
with Medco.
- By Paris Bureau, Dow Jones Newswires; +331-4017-1740;
inti.landauro@dowjones.com
Medco (NYSE:MHS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medco (NYSE:MHS)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Medcohealth Solutions Common Stock (New York Stock Exchange): 0 recent articles
More Medco Health Solutions Inc. News Articles